Skip to main content
Journal of Medical Genetics logoLink to Journal of Medical Genetics
. 1999 Mar;36(3):197–203.

A clinical study of type 1 neurofibromatosis in north west England

J McGaughran 1, D Harris 1, D Donnai 1, D Teare 1, R MacLeod 1, R Westerbeek 1, H Kingston 1, M Super 1, R Harris 1, D Evans 1
PMCID: PMC1734324  PMID: 10204844

Abstract

A clinical study of patients on the North West Regional Genetic Register with neurofibromatosis type 1 (NF1) identified 523 affected cases from 304 families. In those for whom relevant information was available, 86.7% (383 of 442) had more than six café au lait patches, 83.8% (310 of 370) had axillary freckling, 42.3% (151 of 357) had inguinal freckling, and 63% (157 of 249) had Lisch nodules. Cutaneous neurofibromas were present in 59.4% (217 of 365) and 45.5% (150 of 330) were noted to have subcutaneous tumours. Plexiform neurofibromas were present in 15.3% (80 of 523).
A positive family history of NF1 was found in 71.2% (327 of 459) and 28.8% (132 of 459) of affected patients were considered to be the result of a new mutation. Learning difficulties of varying severity occurred in 62% (186 of 300).
CNS tumours associated with NF1 were reported in 9.4% (49) of patients, optic gliomas occurring in 25 of these, 4.8% of patients. Some degree of scoliosis was reported for 11.7% (61), 1.9% (10) had pseudoarthrosis, 4.3% (23) had epilepsy, and 2.1% (11) had spinal neurofibromas.
Actuarial analyses were carried out for both optic glioma and malignant nerve sheath tumours and the data are presented.


Keywords: neurofibromatosis type 1; optic glioma; malignancy; Lisch nodules

Full Text

The Full Text of this article is available as a PDF (116.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BORBERG A. Clinical and genetic investigations into tuberous sclerosis and Recklinghausen's neurofibromatosis; contribution to elucidation of interrelationship and eugenics of the syndromes. Acta Psychiatr Neurol Scand Suppl. 1951;71:1–239. [PubMed] [Google Scholar]
  2. Benjamin C. M., Colley A., Donnai D., Kingston H., Harris R., Kerzin-Storrar L. Neurofibromatosis type 1 (NF1): knowledge, experience, and reproductive decisions of affected patients and families. J Med Genet. 1993 Jul;30(7):567–574. doi: 10.1136/jmg.30.7.567. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Carey J. C., Laub J. M., Hall B. D. Penetrance and variability in neurofibromatosis: a genetic study of 60 families. Birth Defects Orig Artic Ser. 1979;15(5B):271–281. [PubMed] [Google Scholar]
  4. Cawthon R. M., Weiss R., Xu G. F., Viskochil D., Culver M., Stevens J., Robertson M., Dunn D., Gesteland R., O'Connell P. A major segment of the neurofibromatosis type 1 gene: cDNA sequence, genomic structure, and point mutations. Cell. 1990 Jul 13;62(1):193–201. doi: 10.1016/0092-8674(90)90253-b. [DOI] [PubMed] [Google Scholar]
  5. Duffner P. K., Cohen M. E. Isolated optic nerve gliomas in children with and without neurofibromatosis. Neurofibromatosis. 1988;1(4):201–211. [PubMed] [Google Scholar]
  6. Easton D. F., Ponder M. A., Huson S. M., Ponder B. A. An analysis of variation in expression of neurofibromatosis (NF) type 1 (NF1): evidence for modifying genes. Am J Hum Genet. 1993 Aug;53(2):305–313. [PMC free article] [PubMed] [Google Scholar]
  7. Friedman J. M., Birch P. H. Type 1 neurofibromatosis: a descriptive analysis of the disorder in 1,728 patients. Am J Med Genet. 1997 May 16;70(2):138–143. doi: 10.1002/(sici)1096-8628(19970516)70:2<138::aid-ajmg7>3.0.co;2-u. [DOI] [PubMed] [Google Scholar]
  8. Goldgar D. E., Green P., Parry D. M., Mulvihill J. J. Multipoint linkage analysis in neurofibromatosis type I: an international collaboration. Am J Hum Genet. 1989 Jan;44(1):6–12. [PMC free article] [PubMed] [Google Scholar]
  9. Hoyt W. F., Baghdassarian S. A. Optic glioma of childhood. Natural history and rationale for conservative management. Br J Ophthalmol. 1969 Dec;53(12):793–798. doi: 10.1136/bjo.53.12.793. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Huson S. M., Compston D. A., Clark P., Harper P. S. A genetic study of von Recklinghausen neurofibromatosis in south east Wales. I. Prevalence, fitness, mutation rate, and effect of parental transmission on severity. J Med Genet. 1989 Nov;26(11):704–711. doi: 10.1136/jmg.26.11.704. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Huson S. M., Compston D. A., Harper P. S. A genetic study of von Recklinghausen neurofibromatosis in south east Wales. II. Guidelines for genetic counselling. J Med Genet. 1989 Nov;26(11):712–721. doi: 10.1136/jmg.26.11.712. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Huson S. M., Harper P. S., Compston D. A. Von Recklinghausen neurofibromatosis. A clinical and population study in south-east Wales. Brain. 1988 Dec;111(Pt 6):1355–1381. doi: 10.1093/brain/111.6.1355. [DOI] [PubMed] [Google Scholar]
  13. Huson S. M. Recent developments in the diagnosis and management of neurofibromatosis. Arch Dis Child. 1989 May;64(5):745–749. doi: 10.1136/adc.64.5.745. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Lewis R. A., Gerson L. P., Axelson K. A., Riccardi V. M., Whitford R. P. von Recklinghausen neurofibromatosis. II. Incidence of optic gliomata. Ophthalmology. 1984 Aug;91(8):929–935. doi: 10.1016/s0161-6420(84)34217-8. [DOI] [PubMed] [Google Scholar]
  15. Lewis R. A., Riccardi V. M. Von Recklinghausen neurofibromatosis. Incidence of iris hamartomata. Ophthalmology. 1981 Apr;88(4):348–354. doi: 10.1016/s0161-6420(81)35034-9. [DOI] [PubMed] [Google Scholar]
  16. Listernick R., Charrow J., Greenwald M. J., Esterly N. B. Optic gliomas in children with neurofibromatosis type 1. J Pediatr. 1989 May;114(5):788–792. doi: 10.1016/s0022-3476(89)80137-4. [DOI] [PubMed] [Google Scholar]
  17. Listernick R., Charrow J., Greenwald M., Mets M. Natural history of optic pathway tumors in children with neurofibromatosis type 1: a longitudinal study. J Pediatr. 1994 Jul;125(1):63–66. doi: 10.1016/s0022-3476(94)70122-9. [DOI] [PubMed] [Google Scholar]
  18. Lubs M. L., Bauer M. S., Formas M. E., Djokic B. Lisch nodules in neurofibromatosis type 1. N Engl J Med. 1991 May 2;324(18):1264–1266. doi: 10.1056/NEJM199105023241807. [DOI] [PubMed] [Google Scholar]
  19. North K., Joy P., Yuille D., Cocks N., Mobbs E., Hutchins P., McHugh K., de Silva M. Specific learning disability in children with neurofibromatosis type 1: significance of MRI abnormalities. Neurology. 1994 May;44(5):878–883. doi: 10.1212/wnl.44.5.878. [DOI] [PubMed] [Google Scholar]
  20. Pierce S. M., Barnes P. D., Loeffler J. S., McGinn C., Tarbell N. J. Definitive radiation therapy in the management of symptomatic patients with optic glioma. Survival and long-term effects. Cancer. 1990 Jan 1;65(1):45–52. doi: 10.1002/1097-0142(19900101)65:1<45::aid-cncr2820650111>3.0.co;2-z. [DOI] [PubMed] [Google Scholar]
  21. Riccardi V. M., Lewis R. A. Penetrance of von Recklinghausen neurofibromatosis: a distinction between predecessors and descendants. Am J Hum Genet. 1988 Feb;42(2):284–289. [PMC free article] [PubMed] [Google Scholar]
  22. Riccardi V. M., Powell P. P. Neurofibrosarcoma as a complication of von Recklinghausen neurofibromatosis. Neurofibromatosis. 1989;2(3):152–165. [PubMed] [Google Scholar]
  23. Samuelsson B., Axelsson R. Neurofibromatosis. A clinical and genetic study of 96 cases in Gothenburg, Sweden. Acta Derm Venereol Suppl (Stockh) 1981;95:67–71. [PubMed] [Google Scholar]
  24. Seizinger B. R., Rouleau G. A., Ozelius L. J., Lane A. H., Faryniarz A. G., Chao M. V., Huson S., Korf B. R., Parry D. M., Pericak-Vance M. A. Genetic linkage of von Recklinghausen neurofibromatosis to the nerve growth factor receptor gene. Cell. 1987 Jun 5;49(5):589–594. doi: 10.1016/0092-8674(87)90534-4. [DOI] [PubMed] [Google Scholar]
  25. Shen M. H., Harper P. S., Upadhyaya M. Molecular genetics of neurofibromatosis type 1 (NF1). J Med Genet. 1996 Jan;33(1):2–17. doi: 10.1136/jmg.33.1.2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Spence M. A., Sparkes R. S., Parry D. M., Bale S. J., Cortessis V., Mulvihill J. J. Genetic linkage studies with neurofibromatosis: the question of heterogeneity. J Med Genet. 1987 Sep;24(9):527–529. doi: 10.1136/jmg.24.9.527. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Upadhyaya M., Osborn M., Maynard J., Harper P. Characterization of six mutations in exon 37 of neurofibromatosis type 1 gene. Am J Med Genet. 1996 Jul 26;67(4):421–423. doi: 10.1002/(SICI)1096-8628(19960726)67:4<421::AID-AJMG20>3.0.CO;2-K. [DOI] [PubMed] [Google Scholar]
  28. Viskochil D., Buchberg A. M., Xu G., Cawthon R. M., Stevens J., Wolff R. K., Culver M., Carey J. C., Copeland N. G., Jenkins N. A. Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus. Cell. 1990 Jul 13;62(1):187–192. doi: 10.1016/0092-8674(90)90252-a. [DOI] [PubMed] [Google Scholar]
  29. Wallace M. R., Marchuk D. A., Andersen L. B., Letcher R., Odeh H. M., Saulino A. M., Fountain J. W., Brereton A., Nicholson J., Mitchell A. L. Type 1 neurofibromatosis gene: identification of a large transcript disrupted in three NF1 patients. Science. 1990 Jul 13;249(4965):181–186. doi: 10.1126/science.2134734. [DOI] [PubMed] [Google Scholar]
  30. Zehavi C., Romano A., Goodman R. M. Iris (Lisch) nodules in neurofibromatosis. Clin Genet. 1986 Jan;29(1):51–55. doi: 10.1111/j.1399-0004.1986.tb00770.x. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Medical Genetics are provided here courtesy of BMJ Publishing Group

RESOURCES